Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

MELVILLE, N.Y., February 05, 2025--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic trainers (ATs) ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic trainers (ATs) during today’s celebration of National Girls and Women in ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

Henry Schein Inc. closed 8.02% below its 52-week high of $82.63, which the company reached on February 27th.

(“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced a strategic investment by funds ...

Henry Schein, Inc., has announced that Stanley M. Bergman, chairman of the board and CEO, has received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime ...

MELVILLE, N.Y., February 12, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the ...

In its upcoming report, Henry Schein (HSIC) is predicted by Wall Street analysts to post quarterly earnings of $1.19 per share, reflecting an increase of 80.3% compared to the same period last year.